Roivant Sciences Ltd.
ROIV
Rank in Stocks
#974
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Share Price
$33.73
Last synced: 2026-07-31
Market Cap
$24.37B
Change (1 day)
-2.28%
Change (1 year)
88.77%
Country
GB
Trade Roivant Sciences Ltd. (ROIV)
Category
Healthcare
Stock price history for Roivant Sciences Ltd. (ROIV)
Highest end of day price: $34.87 on 2026-07-01
Lowest end of day price: $10.07 on 2020-12-01
Lowest end of day price: $10.07 on 2020-12-01
Stock price history of Roivant Sciences Ltd. from 2020 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 23.49% |
| 2025 | 80.37% |
| 2024 | 13.38% |
| 2023 | 50.58% |
| 2022 | -31.41% |
| 2021 | 1.51% |
| 2020 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
